Millennium Management’s Apellis Pharmaceuticals APLS Stock Holding History

Millennium Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-71,300	Closed	-$2.28M	–	5820
2024 Q4	$2.28M	Buy	71,300 +53,700	+305%	+$1.61M	﹤0.01%	3524
2024 Q3	$508K	Sell	17,600 -1,000	-5%	-$37K	﹤0.01%	4825
2024 Q2	$713K	Sell	18,600 -31,400	-63%	-$1.42M	﹤0.01%	4364
2024 Q1	$2.94M	Sell	50,000 -75,500	-60%	-$4.81M	﹤0.01%	3391
2023 Q4	$7.51M	Buy	125,500 +84,500	+206%	+$4.29M	﹤0.01%	2440
2023 Q3	$1.56M	Sell	41,000 -51,200	-56%	-$2.25M	﹤0.01%	3802
2023 Q2	$8.4M	Buy	92,200 +62,200	+207%	+$5.37M	﹤0.01%	2189
2023 Q1	$1.98M	Buy	+30,000	New	+$1.73M	﹤0.01%	3460
2022 Q3	–	Sell	-170,000	Closed	-$7.69M	–	7037
2022 Q2	$7.69M	Buy	170,000 +150,000	+750%	+$6.84M	﹤0.01%	2339
2022 Q1	$1.02M	Sell	20,000 -180,000	-90%	-$7.95M	﹤0.01%	4498
2021 Q4	$9.46M	Buy	200,000 +150,000	+300%	+$5.91M	﹤0.01%	2201
2021 Q3	$1.65M	Buy	50,000 +34,800	+229%	+$1.96M	﹤0.01%	4138
2021 Q2	$961K	Sell	15,200 -84,800	-85%	-$4.38M	﹤0.01%	4704
2021 Q1	$4.29M	Buy	+100,000	New	+$4.73M	﹤0.01%	2749
2020 Q4	–	Sell	-100,000	Closed	-$3.02K	–	5171
2020 Q3	$3.02K	Buy	+100,000	New	+$2.99M	﹤0.01%	2275
2020 Q1	–	Sell	-225,000	Closed	-$6.89M	–	3810
2019 Q4	$6.89M	Sell	225,000 -75,000	-25%	-$2.08M	0.01%	1665
2019 Q3	$7.23M	Buy	+300,000	New	+$8.26M	0.01%	1514

Other funds holding APLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management's APLS Position: Q1 2026 in Review

Millennium Management increased its Apellis Pharmaceuticals (APLS) stake by 138% in Q1 2026, buying an estimated $28.2M and bringing the position to 2,256,802 shares worth $90.8M. The position accounts for 0.04% of the portfolio, ranked #491.

Millennium Management first reported a position in APLS in Q2 2018 and has held it in 30 quarters since. 321 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

Millennium Management held 2,256,802 shares of Apellis Pharmaceuticals worth $90.8M as of Q1 2026.
Millennium Management bought 1,310,343 Apellis Pharmaceuticals shares in Q1 2026, an estimated $28.2M.
Apellis Pharmaceuticals made up 0.04% of Millennium Management's portfolio in Q1 2026, its #491 holding.
Millennium Management first reported a position in Apellis Pharmaceuticals in Q2 2018 and has held it in 30 quarters since.
321 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.